期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

核医学肿瘤乏氧显像研究进展

Research advancement on hypoxia imaging of nuclear medicine in tumors
下载PDF
导出
摘要 肿瘤组织乏氧显像对于肿瘤的早期诊断、治疗方案的确定及疗效预后评价具有重要意义,本文介绍了核医学肿瘤乏氧显像剂的分类,根据显像方法分别阐述了SPECT和PET在乏氧显像研究中的进展,并对各显像方法进行了评价。 This paper introduces the development of hypoxia imaging of nuclear medicine in tumors,appraises the advantage and defect of each imaging agents.
作者 杨星 任庆余 张延华
机构地区 白求恩国际和平医院核医学科
出处 《现代肿瘤医学》 CAS 2011年第4期799-801,共3页 Journal of Modern Oncology
关键词 核医学 乏氧显像 显像剂 肿瘤 nuclear medicine hypoxia imaging imaging agents tumor
分类号 R730.44 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1Brizel DM,Scully SP,Harrelson JM,et al.Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma[J].Cancer Res,1996,56:941-943.
  • 2De-Carvalho KM,Monteiro GB,Temporini ER,et al.Acceptance regarding use of optical aids among low vision elderly people[J].Int Congress Series,2005,1282:60-63.
  • 3Lewis JS,Welch MJ.PET imaging of hypoxia[J].QJ Nucl Med,2001,45:183-188.
  • 4Ballinger JR.Imaging hypoxia in tumors[J].Sem in Nucl Med,2001,31:321-329.
  • 5Inathashi K,Morishita K,Kusuoka H,et al.Kinetics of a putative hypoxic tracer,99mTc-HL91,in nomoxic,hypoxic,ischemic,and stunned myocardium[J].J Nucl Med,2000,41:1102-1107.
  • 6Zhang X,Melo T,Ballinger JR,et al.Studies of 99mTcBnAO(HL91):a non-nitroaromatic compound for hypoxic cell diction[J].Int J Radiat Oncol Biol Phys,1998,42:737-740.
  • 7SiimBG,Laux WT,Rutland MD,et al.Scintigraphic imaging of the hypoxia marker 99mTc labeled 2,2′ (1,4 -diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91;prognox):noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid[J].Cancer Res,2000,60:4582-4588.
  • 8Suzuki T,Nakamura K,Kawase T,et al.Biodistribution of hypoxia maker,99mTc-HL91[J].Kaku Igaku-JPN J Nucl Med,2001,38(4):333-341.
  • 9Riche F,Hardermare AD,Sepe S,et al.Nitroimidazoles and hypoxia imaging synthesis of three 99mTc-complexes bearing a nitroimidazole group:biological results[J].Bioorg Med Chem Lett,2001,11:71-74.
  • 10Meb T,Duncan J,Ballinger JR,et al.BRU59-21,a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors[J].J Nucl Med,200,41:169-176.

二级参考文献41

  • 1张锦明,郭喆,田嘉禾,刘伯里.自动化合成^(18)F-FDDNP及其生物学分布[J].中华核医学杂志,2005,25(3):140-141. 被引量：11
  • 2彭程,汪建军,朱霖,马云川.在CPCU上自动化合成^(18)FMISO[J].同位素,2006,19(3):173-176. 被引量：8
  • 3Patterson RE.Value of objective assessment of new radiopharmaceuticals[J].J Nucl Med,1995,36(36):1086-1089.
  • 4Nakamura S.Structure of azomycin,a new antibiotic[J].Pharm Bull,1955,3(5):379-383.
  • 5Nunn A,Linder K,Strauss HW,et al.Nitroimidazoles and imaging hypoxia[J].EurJ Nucl Med,1995,22(3):265-280.
  • 6Mannan RH,Somayaji VV,Lee J,et al.Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycinarabinoside:IAZA):a novel marker of tissue hypoxia[J].J Nucl Med,1991,32(9):1764-1770.
  • 7Archer MC,Ewards B,Powell NA.Radio-pharmaceuticals for imaging hypoxia[A].In:Mather SJ,ed.Current directions in radiopharma-ceutical research and development[M].Netherlands:Kluwer,1996.81-88.
  • 8Ballinger JR.Imaging hypoxia in tumors[J].Semi Nucl Med,2001,31(4):321-329.
  • 9Van De Viele C,Versijpt J,Dierckx RA,et al.99Tc(m)lacelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma[J].Nucl Med Commun,2001,22(3):269-275.
  • 10Grunbaum Z,Freauff SJ,Krohn KA,et al.Synthesis and characterization of congeners of misonidazole for imaging hypoxia[J].J Nucl Med,1987,28(1):68-75.

共引文献13

现代肿瘤医学
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部